← Eichor
Study identifier: NCT06612034 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

Prostate Cancer Care Disparity Analysis Project (ProGAP)

Condition: Prostate CA  ·  Sponsor: Ankara University

PhaseN/A
Planned participants400
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income, lower-middle-income, upper-middle-income, and high-income. The primary question it addresses is: Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide? To achieve this, we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications. Participants will complete a 17-question online survey.

This description comes directly from the study's public registry record.

Talk to the study team

Yüksel Ürün  ·  800-555-5555  ·  yukselurun@gmail.com

Satı Coşkun Yazgan  ·  800-555-5555  ·  coskunyazgann491@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ankara University Faculty of MedicineAnkara, Ankara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06612034